Sachi Okawa

MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I

Johannes Brägelmann, Carina Lorenz, Sven Borchmann et al. · Nature Communications · 2021 · 76 citations · Full text

Medicine, Cancer Biology, Oncology +17

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

Hiromi Watanabe, Eiki Ichihara, Hiroe Kayatani et al. · Cancer Science · 2021 · 55 citations · Full text

Medicine, Oncology, Pharmacology +17

Pembrolizumab-induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in Non-small Cell Lung Cancer

Sachi Okawa, Hiroe Kayatani, Keiichi Fujiwara et al. · Internal Medicine · 2019 · 47 citations · Full text

Life Sciences, Hematology, Oncology +13

CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in <i>Egfr</i> -Mutant Lung Cancer

Kazuya Nishii, Kadoaki Ohashi, Shuta Tomida et al. · Cancer Immunology Research · 2022 · 25 citations

Medicine, Immunology, Oncology +17

Identification of targetable kinases in idiopathic pulmonary fibrosis

Hisao Higo, Kadoaki Ohashi, Shuta Tomida et al. · Respiratory Research · 2022 · 17 citations · Full text

Medicine, Molecular Biology, Pathology +17